Innovating Works

RBHT

Desconocido
ARISE: Aortic Valve Replacement using Individualised Regenerative Allografts Bridging the Therapeutic Gap Royal Brompton Harefield NHS Foundation Trust participó en un H2020: H2020-PHC-2014-2015 65,000 aortic valve replacements (AVR) are performed in Europe each year to treat acquired and congenital aortic valve diseases. In affected...
2014-12-01 - 2019-03-31 | Financiado
IABC PROGRAMME: iABC Programme Royal Brompton Harefield NHS Foundation Trust participó en un FP6: Cystic Fibrosis (CF) is a common fatal inherited disease with a frequency of 1 in 2500 live births, affecting approximately 36,000 (0.737/10...
2015-08-01 - 2021-12-31 | Financiado
PRO- ACTIVE: Physical Activity as a Crucial Patient Reported Outcome in COPD Royal Brompton Harefield NHS Foundation Trust participó en un FP6: Physical activity (PA) is essential in maintaining optimal health in chronic diseases, including COPD.More physically active patients have l...
2009-09-01 - 2016-05-31 | Financiado
EVINCI-STUDY: Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Di... Royal Brompton Harefield NHS Foundation Trust participó en un FP7: The main purpose of the EVINCI-study is to test the impact of combined anatomo-functional non invasive cardiac imaging for detection and cha...
Financiado
PRO- ACTIVE: Physical Activity as a Crucial Patient Reported Outcome in COPD Royal Brompton Harefield NHS Foundation Trust participó en un FP7: Physical activity (PA) is essential in maintaining optimal health in chronic diseases, including COPD.More physically active patients have l...
Financiado
PREPARE: Platform foR European Preparedness Against Re emerging Epidemics Royal Brompton Harefield NHS Foundation Trust participó en un FP7: Far from receding, the threats posed by infections with epidemic potential grow ever greater. Although Europe has amongst the best healthcar...
Financiado
IABC PROGRAMME: iABC Programme Royal Brompton Harefield NHS Foundation Trust participó en un FP7: Cystic Fibrosis (CF) is a common fatal inherited disease with a frequency of 1 in 2500 live births, affecting approximately 36,000 (0.737/10...
Financiado
EURIPFNET: European IPF Network Natural course Pathomechanisms and Novel Treatment Options in Idiopathic Pulm... Royal Brompton Harefield NHS Foundation Trust participó en un FP7: In the eurIPFnet consortium, leading European basic and clinical scientists in the field of interstitial lung diseases associate to jointly...
Financiado
CHILD-EU: Orphans Unite chILD better together European Management Platform for Childhood Interstitial Lung D... Royal Brompton Harefield NHS Foundation Trust participó en un FP7: Children with diffuse lung disease, also called childhood interstitial lung diseases (chILD), may have one of more than 200 entities, the bi...
Financiado
BESTCILIA: Better Experimental Screening and Treatment for Primary Ciliary Dyskinesia Royal Brompton Harefield NHS Foundation Trust participó en un FP7: Primary Ciliary Dyskinesia (PCD) is a rare genetically heterogeneous disorder which results from dysfunction of motile hair-like organelles...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.